Rutgers Cancer Institute and RWJBarnabas Health in collaboration with New Jersey Medical School/University Hospital Liver Transplantation group serve as the state’s only multidisciplinary healthcare team focused on liver, gallbladder, and bile duct tumors as well as pre-malignant lesions.
As the largest referral center in the state for these cancers, the multidisciplinary group of health care professionals comes together to provide multidisciplinary, comprehensive, high-quality, compassionate, and personalized care tailored to meet the needs of each individual patient.
Conditions We Treat
Together with RWJBarnabas Health, we specialize in advanced treatments for complex tumors of the liver, gallbladder and bile duct, offering a full spectrum of care with both minimally invasive and state-of-the-art surgical techniques.
- Liver Cancer (Primary liver cancer and metastatic disease to the liver)
- Gallbladder Cancer
- Bile duct Cancer
- Premalignant and benign lesions of the liver, gallbladder, and bile ducts
Explore all Cancer Surgical Services at Rutgers Cancer Institute →
Why Choose us for Your Hepatobiliary Cancer Care?
Leading Hepatobiliary Experts
We treat a wide range of liver, gallbladder, and bile duct cancers, ranging from a primary cancer diagnosis such as hepatocellular carcinoma (HCC), cholangiocarcinoma (bile duct cancer), and gallbladder cancer to metastatic liver cancer such as colorectal cancer, neuroendocrine cancer, and others.
Furthermore, we manage and treat a large variety of premalignant and benign liver, gallbladder, and bile duct lesions, such as hepatic adenomas, hepatic cysts, bile duct congenital abnormalities such as choledochal cysts, gallbladder polyps, and traumatic injuries to these structures such as bile duct injuries.
State-of-the-Art Surgical Care
As New Jersey’s only National Cancer Institute (NCI)-Designated Comprehensive Cancer Center, we offer the latest and most cutting-edge diagnostic and surgical therapies, such as robotic surgery; liver parenchyma sparing techniques; microwave ablation navigation therapy; hepatic arterial infusion pump therapy; liver transplantation for HCC as well as unresectable colorectal liver metastases, perhilar cholangiocarcinoma (Klatskin’s tumor), and intrahepatic cholangiocarcinoma, all delivered throughout the state of New Jersey with care close to home.
Continued Advancement of Cancer Care
Our clinical trial portfolio for each of these disease processes is expansive, bringing the lastest national clinical trials locally to the patients we serve. In addition to serving our patients, the surgical oncologists at Rugters Cancer Institute are dedicated to educating the next generation and future leaders in the field of surgical oncology, housing the only Complex General Surgical Oncology Fellowship Program within the state of New Jersey.
Meet Our Team
H. Richard Alexander, Jr., MD, FACS
Chief Surgical Officer,
Chief, Surgical Oncology, Rutgers Cancer Institute;
System Director of Surgical Oncology, RWJBarnabas Health;
Regional Director of Surgery for Monmouth Medical Center, an RWJBH Facility
Assistant Professor in the Department of Surgery, Rutgers Robert Wood Johnson Medical School
Brett Ecker, MD
Surgical Oncologist
Assistant Professor in the Department of Surgery, Rutgers Robert Wood Johnson Medical School
Mariam Eskander, MD, MPH
Surgical Oncologist
Assistant Professor in the Department of Surgery, Rutgers Robert Wood Johnson Medical School
Russell C. Langan, MD, FACS, FSSO
Associate Chief Surgical Officer, System Integration and Quality
Director of Surgical Oncology, Northern Region, RWJBarnabas Health | Rutgers Cancer Institute
Chief of Surgical Oncology & Hepatopancreatobiliary Surgery, Cooperman Barnabas Medical Center
Surgical Oncologist
Related Articles and Press
Expert Explains Rare Biliary Tract Cancers
Although considered a rare disease according to the American Cancer Society, gallbladder and bile duct cancers (also known as hepatobiliary cancers) affect thousands of people in the U.S. each year.
Several RWJBarnabas Health Facilities Earn National Accreditation from the Commission on Cancer of the American College of Surgeons
Cancer programs at several RWJBarnabas Health facilities, in partnership with Rutgers Cancer Institute, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, were recently granted Three-Year Accreditation from the American College of Surgeons Commission on Cancer (CoC).